Faruque Ghanchi

2.5k total citations · 1 hit paper
50 papers, 1.1k citations indexed

About

Faruque Ghanchi is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Faruque Ghanchi has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Ophthalmology, 32 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Faruque Ghanchi's work include Retinal Diseases and Treatments (35 papers), Retinal Imaging and Analysis (31 papers) and Retinal and Optic Conditions (29 papers). Faruque Ghanchi is often cited by papers focused on Retinal Diseases and Treatments (35 papers), Retinal Imaging and Analysis (31 papers) and Retinal and Optic Conditions (29 papers). Faruque Ghanchi collaborates with scholars based in United Kingdom, Germany and France. Faruque Ghanchi's co-authors include Winfried M. K. Amoaku, Richard Gale, Yit C. Yang, James Talks, Björn Rembacken, Sobha Sivaprasad, Gordon N. Dutton, Andrew Lotery, Simon Harding and Sajjad Mahmood and has published in prestigious journals such as The Lancet, Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Faruque Ghanchi

47 papers receiving 1.1k citations

Hit Papers

Defining response to anti-VEGF therapies in neovascular AMD 2015 2026 2018 2022 2015 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faruque Ghanchi United Kingdom 18 854 629 167 114 89 50 1.1k
Genevieve Larkin United Kingdom 13 613 0.7× 280 0.4× 104 0.6× 121 1.1× 131 1.5× 21 1.2k
Dimitrios Papaconstantinou Greece 21 884 1.0× 678 1.1× 125 0.7× 103 0.9× 30 0.3× 126 1.4k
Anton Haas Austria 21 1.8k 2.1× 1.2k 1.8× 272 1.6× 113 1.0× 117 1.3× 90 2.2k
Bora Eldem Türkiye 20 1.4k 1.6× 883 1.4× 183 1.1× 62 0.5× 124 1.4× 54 1.6k
Ruth Axer‐Siegel Israel 28 1.7k 1.9× 1.3k 2.1× 202 1.2× 229 2.0× 63 0.7× 97 2.2k
Qianli Meng China 17 717 0.8× 269 0.4× 130 0.8× 72 0.6× 176 2.0× 45 989
James Talks United Kingdom 25 1.8k 2.0× 1.4k 2.2× 219 1.3× 42 0.4× 30 0.3× 88 2.0k
Philipp S. Muether Germany 27 1.3k 1.5× 1.1k 1.8× 296 1.8× 97 0.9× 29 0.3× 55 1.7k
Adriano Carnevali Italy 28 1.9k 2.3× 1.6k 2.5× 244 1.5× 51 0.4× 37 0.4× 102 2.3k
Ramak Roohipoor Iran 18 809 0.9× 713 1.1× 98 0.6× 237 2.1× 38 0.4× 62 1.1k

Countries citing papers authored by Faruque Ghanchi

Since Specialization
Citations

This map shows the geographic impact of Faruque Ghanchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faruque Ghanchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faruque Ghanchi more than expected).

Fields of papers citing papers by Faruque Ghanchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faruque Ghanchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faruque Ghanchi. The network helps show where Faruque Ghanchi may publish in the future.

Co-authorship network of co-authors of Faruque Ghanchi

This figure shows the co-authorship network connecting the top 25 collaborators of Faruque Ghanchi. A scholar is included among the top collaborators of Faruque Ghanchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faruque Ghanchi. Faruque Ghanchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Danzig, Carl J., Christiana Dinah, Faruque Ghanchi, et al.. (2025). Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion. Ophthalmology Retina. 9(9). 848–859. 2 indexed citations
5.
Dinah, Christiana, et al.. (2023). Inclusive research in ophthalmology is mission critical! The 10-point action plan. Eye. 38(2). 235–237. 1 indexed citations
6.
Chandra, Shruti, Sarega Gurudas, Ian Pearce, et al.. (2023). Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3. Eye. 38(7). 1301–1307. 2 indexed citations
7.
Chandra, Shruti, Sarega Gurudas, Ben Burton, et al.. (2023). Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2. Eye. 38(4). 757–765. 6 indexed citations
8.
Sivaprasad, Sobha, Faruque Ghanchi, Simon P. Kelly, et al.. (2023). Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes. Eye. 37(13). 2753–2760. 3 indexed citations
9.
Qahwaji, Rami, et al.. (2023). Review of substitutive assistive tools and technologies for people with visual impairments: recent advancements and prospects. Journal on Multimodal User Interfaces. 18(1). 135–156. 25 indexed citations
10.
Pető, Tünde, Rebecca Evans, Barnaby C Reeves, et al.. (2022). Long-term Retinal Morphology and Functional Associations in Treated Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 6(8). 664–675. 11 indexed citations
11.
Sivaprasad, Sobha, Faruque Ghanchi, Simon P. Kelly, et al.. (2021). Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes. Eye. 36(1). 64–71. 7 indexed citations
12.
Lois, Noemi, Jonathan Cook, Ariel Wang, et al.. (2021). Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study. Health Technology Assessment. 25(32). 1–104. 2 indexed citations
13.
Sivaprasad, Sobha, Katie Banister, Beatriz Goulão, et al.. (2021). Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration. Ophthalmology. 128(12). 1736–1747. 21 indexed citations
14.
Amoaku, Winfried M. K., Clare Bailey, Louise Downey, et al.. (2020). <p>Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service Delivery</p>. Clinical ophthalmology. Volume 14. 1315–1328. 8 indexed citations
15.
Ghanchi, Faruque, Sobha Sivaprasad, Konstantinos Balaskas, et al.. (2019). Acceptability of OCT angiography: A multicentre OCT Angiography NEtwork (OCTANE) study. Investigative Ophthalmology & Visual Science. 60(9). 3477–3477. 1 indexed citations
16.
Lois, Noemi, Jonathan Cook, S J Aldington, et al.. (2019). Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD). BMJ Open. 9(6). e027795–e027795. 4 indexed citations
17.
Gale, Richard, Peter H. Scanlon, Marc Evans, et al.. (2017). Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease. Eye. 31(S1). S1–S20. 33 indexed citations
18.
Amoaku, Winfried M. K., Usha Chakravarthy, Richard Gale, et al.. (2015). Defining response to anti-VEGF therapies in neovascular AMD. Eye. 29(6). 721–731. 262 indexed citations breakdown →
19.
Qahwaji, Rami, et al.. (2014). Preparation of 2D sequences of corneal images for 3D model building. Computer Methods and Programs in Biomedicine. 114(2). 194–205. 10 indexed citations
20.
Ghanchi, Faruque. (1996). Ocular Tumoral Calcinosis. Archives of Ophthalmology. 114(3). 341–341. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026